OCULAR THERAPEUTIX, INC Property, Plant and Equipment, Gross
OCULAR THERAPEUTIX, INC (OCUL) had Property, Plant and Equipment, Gross of $47.20 million as of 2025-12-31, per its 10-K filed 2026-02-05.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentGross · last filed 2026-02-05
- 2025-12-31: Property, Plant and Equipment, Gross $47.20M.
- 2024-12-31: Property, Plant and Equipment, Gross $33.02M.
- 2023-12-31: Property, Plant and Equipment, Gross $32.00M.
- 2022-12-31: Property, Plant and Equipment, Gross $27.13M.
| Period end | Property, Plant and Equipment, Gross |
|---|---|
| 2025-12-31 | $47.20M 10-K · filed 2026-02-05 |
| 2024-12-31 | $33.02M 10-K · filed 2026-02-05 |
| 2023-12-31 | $32.00M 10-K · filed 2025-03-03 |
| 2022-12-31 | $27.13M 10-K · filed 2024-03-11 |
| 2021-12-31 | $22.16M 10-K · filed 2023-03-06 |
| 2020-12-31 | $20.88M 10-K · filed 2022-02-28 |
| 2019-12-31 | $20.17M 10-K · filed 2021-03-11 |
| 2018-12-31 | $17.86M 10-K · filed 2020-03-12 |
| 2017-12-31 | $15.82M 10-K · filed 2019-03-07 |
| 2017-09-30 | $15.05M 10-Q · filed 2017-11-07 |
| 2016-12-31 | $7.13M 10-K · filed 2018-03-08 |
| 2015-12-31 | $6.03M 10-K · filed 2017-03-10 |
| 2014-12-31 | $4.00M 10-K · filed 2016-03-10 |
| 2013-12-31 | $2.58M 10-K · filed 2015-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 | |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |